Front Row Advisors’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.06M | Sell |
6,978
-10
| -0.1% | -$2.97K | 0.7% | 39 |
|
|
2025
Q4 | $1.91M | Sell |
6,988
-30
| -0.4% | -$8.15K | 0.64% | 39 |
|
|
2025
Q3 | $1.9M | Sell |
7,018
-50
| -0.7% | -$13.6K | 0.64% | 39 |
|
|
2025
Q2 | $1.95M | Sell |
7,068
-10
| -0.1% | -$2.72K | 0.68% | 40 |
|
|
2025
Q1 | $1.88M | Sell |
7,078
-89
| -1% | -$22K | 0.72% | 38 |
|
|
2024
Q4 | $1.71M | Buy |
7,167
+15
| +0.2% | +$3.45K | 0.59% | 43 |
|
|
2024
Q3 | $1.58M | Sell |
7,152
-140
| -2% | -$29K | 0.56% | 45 |
|
|
2024
Q2 | $1.43M | Buy |
7,292
+20
| +0.3% | +$4.13K | 0.5% | 48 |
|
|
2024
Q1 | $1.57M | Buy |
7,272
+30
| +0.4% | +$6.3K | 0.58% | 43 |
|
|
2023
Q4 | $1.56M | Sell |
7,242
-105
| -1% | -$22.4K | 0.72% | 40 |
|
|
2023
Q3 | $1.47M | Sell |
7,347
-10
| -0.1% | -$1.99K | 0.68% | 42 |
|
|
2023
Q2 | $1.36M | Buy |
7,357
+45
| +0.6% | +$8.32K | 0.61% | 48 |
|
|
2023
Q1 | $1.4M | Sell |
7,312
-225
| -3% | -$40.7K | 0.67% | 43 |
|
|
2022
Q4 | $1.3M | Sell |
7,537
-914
| -11% | -$159K | 0.67% | 47 |
|
|
2022
Q3 | $1.5M | Sell |
8,451
-85
| -1% | -$16.8K | 0.77% | 44 |
|
|
2022
Q2 | $1.75M | Sell |
8,536
-31
| -0.4% | -$6.57K | 0.86% | 37 |
|
|
2022
Q1 | $2.04M | Sell |
8,567
-30
| -0.3% | -$7.05K | 0.82% | 37 |
|
|
2021
Q4 | $1.99M | Buy |
8,597
+30
| +0.4% | +$6.6K | 0.74% | 43 |
|
|
2021
Q3 | $1.66M | Buy |
8,567
+25
| +0.3% | +$5.07K | 0.7% | 49 |
|
|
2021
Q2 | $1.69M | Buy |
8,542
+400
| +5% | +$84.5K | 0.69% | 51 |
|
|
2021
Q1 | $1.66M | Buy |
8,142
+295
| +4% | +$58.1K | 0.81% | 41 |
|
|
2020
Q4 | $1.45M | Sell |
7,847
-130
| -2% | -$22.1K | 0.74% | 46 |
|
|
2020
Q3 | $1.39M | Sell |
7,977
-100
| -1% | -$16.8K | 0.74% | 45 |
|
|
2020
Q2 | $1.31M | Sell |
8,077
-125
| -2% | -$22.4K | 0.81% | 41 |
|
|
2020
Q1 | $1.46M | Sell |
8,202
-46
| -0.6% | -$9.16K | 0.99% | 31 |
|
|
2019
Q4 | $1.68M | Sell |
8,248
-419
| -5% | -$86K | 1.09% | 28 |
|
|
2019
Q3 | $1.83M | Sell |
8,667
-20
| -0.2% | -$4.18K | 1.31% | 18 |
|
|
2019
Q2 | $1.69M | Sell |
8,687
-135
| -2% | -$24.9K | 1.23% | 23 |
|
|
2019
Q1 | $1.45M | Buy |
8,822
+130
| +1% | +$23K | 1.13% | 28 |
|
|
2018
Q4 | $1.65M | Sell |
8,692
-225
| -3% | -$41.5K | 1.44% | 15 |
|
|
2018
Q3 | $1.61K | Buy |
8,917
+35
| +0.4% | +$5.89K | 1.13% | 19 |
|
|
2018
Q2 | $1.51K | Buy |
8,882
+335
| +4% | +$54.7K | 0.96% | 24 |
|
|
2018
Q1 | $1.38M | Buy |
8,547
+213
| +3% | +$33.9K | 0.97% | 27 |
|
|
2017
Q4 | $1.22M | Buy |
+8,334
| New | +$1.19M | 0.97% | 30 |
|
Other funds holding CME
VCM
VPM
Front Row Advisors's CME Position: Q1 2026 in Review
Front Row Advisors reduced its CME Group (CME) stake by 0.14% in Q1 2026, selling an estimated $2.97K and leaving 6,978 shares worth $2.06M. The position accounts for 0.7% of the portfolio, ranked #39.
Front Row Advisors first reported a position in CME in Q4 2017 and has held it in 34 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Front Row Advisors held 6,978 shares of CME Group worth $2.06M as of Q1 2026.
- Front Row Advisors sold 10 CME Group shares in Q1 2026, an estimated $2.97K.
- CME Group made up 0.7% of Front Row Advisors's portfolio in Q1 2026, its #39 holding.
- Front Row Advisors first reported a position in CME Group in Q4 2017 and has held it in 34 quarters since.
- 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Front Row Advisors's 13F filing for Q1 2026, filed 19 May 2026.